Russell Investments Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.4M | Buy |
638,845
+557,176
| +682% | +$6.45M | 0.01% | 991 |
|
|
2025
Q1 | $713K | Buy |
81,669
+64,851
| +386% | +$566K | ﹤0.01% | 2172 |
|
|
2024
Q4 | $242K | Buy |
16,818
+6,932
| +70% | +$99.5K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $223K | Sell |
9,886
-137,579
| -93% | -$3.11M | ﹤0.01% | 2486 |
|
|
2024
Q2 | $2.87M | Buy |
147,465
+1,021
| +0.7% | +$19.9K | ﹤0.01% | 1451 |
|
|
2024
Q1 | $5.5M | Buy |
146,444
+134,598
| +1,136% | +$5.05M | 0.01% | 1125 |
|
|
2023
Q4 | $663K | Sell |
11,846
-48
| -0.4% | -$2.69K | ﹤0.01% | 2126 |
|
|
2023
Q3 | $491K | Sell |
11,894
-13,842
| -54% | -$571K | ﹤0.01% | 2231 |
|
|
2023
Q2 | $1.44M | Sell |
25,736
-5,422
| -17% | -$303K | ﹤0.01% | 1739 |
|
|
2023
Q1 | $1.74M | Buy |
31,158
+880
| +3% | +$49.1K | ﹤0.01% | 1670 |
|
|
2022
Q4 | $1.1M | Buy |
30,278
+28,100
| +1,290% | +$1.02M | ﹤0.01% | 1922 |
|
|
2022
Q3 | $61K | Sell |
2,178
-352,303
| -99% | -$9.87M | ﹤0.01% | 2727 |
|
|
2022
Q2 | $16M | Sell |
354,481
-24,276
| -6% | -$1.1M | 0.03% | 585 |
|
|
2022
Q1 | $28.8M | Buy |
378,757
+130,149
| +52% | +$9.9M | 0.05% | 443 |
|
|
2021
Q4 | $37M | Sell |
248,608
-28,942
| -10% | -$4.31M | 0.06% | 384 |
|
|
2021
Q3 | $40.4M | Sell |
277,550
-5,494
| -2% | -$800K | 0.07% | 350 |
|
|
2021
Q2 | $55.4M | Buy |
283,044
+24,598
| +10% | +$4.82M | 0.09% | 258 |
|
|
2021
Q1 | $46.8M | Buy |
258,446
+251,583
| +3,666% | +$45.5M | 0.08% | 294 |
|
|
2020
Q4 | $973K | Buy |
+6,863
| New | +$973K | ﹤0.01% | 2128 |
|
|
2020
Q3 | – | Sell |
-5,121
| Closed | -$457K | – | 3258 |
|
|
2020
Q2 | $457K | Buy |
5,121
+3,199
| +166% | +$285K | ﹤0.01% | 2408 |
|
|
2020
Q1 | $119K | Buy |
+1,922
| New | +$119K | ﹤0.01% | 2683 |
|